We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Phase 1 Trial of Everolimus and Gefitinib in Patients With Advanced Nonsmall-Cell Lung Cancer.
- Authors
Milton, Daniel T.; Riely, Gregory J.; Azzoli, Christopher G.; Gomez, Jorge E.; Heelan, Robert T.; Kris, Mark G.; Krug, Lee M.; Pao, William; Pizzo, Barbara; Rizvi, Naiyer A.; Miller, Vincent A.
- Abstract
The article provides information on a study that determined a daily dose of everolimus with gefitinib in patients with advanced nonsmall-cell lung cancer. It describes methodology used in the study. It concludes that everolimus at a dose of 5 milligrams (mg) daily in combination with daily gefitinib 250 mg is recommended.
- Subjects
SMALL cell lung cancer; LUNG cancer; ANTINEOPLASTIC agents; CANCER treatment; DOSAGE forms of drugs
- Publication
Cancer (0008543X), 2007, Vol 110, Issue 3, p599
- ISSN
0008-543X
- Publication type
Article
- DOI
10.1002/cncr.22816